#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cystic fibrosis Leukocyte adhesion deficiency type I Post transplant lymphoproliferative disorder Piriformis syndrome Ductal adenocarcinoma of pancreas Cerebral arteriovenous malformation haemorrhagic Crohn's disease Urethral valves Solitary fibrous tumour Trigeminal neuralgia Mucopolysaccharidosis II Factor IX deficiency Warm autoimmune haemolytic anaemia Autoimmune disorder Isodicentric chromosome 15 syndrome More trials…

    Learn about Rare Diseases

    Gastrointestinal stromal tumour – Trials in Disease Ewing’s sarcoma – Life with Disease Skin angiosarcoma – Trials in Disease Sarcoidosis Mantle cell lymphoma stage IV Crigler-Najjar syndrome – Life with Disease Alexander disease – Life with Disease Mantle cell lymphoma refractory Pulmonary sarcoidosis – Diagnostics Ewing’s sarcoma recurrent – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dolutegravir Eo2317 Bilastine Azd7798 Gns561 Luspatercept Alx148 ZUNIBERGENE ROCPARVOVEC Pembrolizumab Ampicillin Sodium Olmesartan Medoxomil ABBV-CLS-628 Fluciclovine (18F) Alisertib Sodium SP16 Al8326 Chlorpromazine Cdr132L Sodium Roginolisib Rondaptivon Pegol More therapies…

    Learn about Your Condition

    Neuromyopathy Somatic symptom disorder Staphylococcal infection Diabetes mellitus Cutaneous lupus erythematosus Cardiac sarcoidosis Coronary artery disease Adenocarcinoma gastric Hodgkin's disease Albuminuria Still's disease Juvenile absence epilepsy Ventricular extrasystoles Eructation Meniscus injury More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Chronic myeloid leukaemia

  • Study on Stopping Dasatinib in Patients with Chronic Myeloid Leukemia After a Previous Attempt to Stop Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic myeloid leukaemia
    Investigated Drugs:
    • Dasatinib
    Denmark France The Netherlands

  • Study of Asciminib treatment for patients with Chronic Myeloid Leukemia who have T315I mutation and cannot take or tolerate ponatinib

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic myeloid leukaemia
    Investigated Drugs:
    • Asciminib Hydrochloride
    France

  • Study on Ponatinib for Treating Recurrent or Refractory Leukemias and Solid Tumors in Children

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Myeloid leukaemia
    • Chronic myeloid leukaemia
    • Acute leukaemia
    Investigated Drugs:
    • Ponatinib
    Belgium France Italy The Netherlands Spain Sweden

  • Study on the Dose and Safety of Asciminib in Children with Chronic Myeloid Leukemia

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Juvenile chronic myelomonocytic leukaemia
    • Philadelphia positive chronic myeloid leukaemia
    • Chronic myeloid leukaemia
    Investigated Drugs:
    • Asciminib
    • Asciminib Hydrochloride
    France Germany Greece Hungary Italy The Netherlands +1

  • Efficacy of asciminib in chronic phase chronic myeloid leukemia patients with T315I mutation

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Asciminib Hydrochloride
    Germany

  • Study for Adults with Chronic Myeloid Leukemia Using Asciminib Alone or with Nilotinib

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Asciminib Hydrochloride
    • Nilotinib
    Italy Spain
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!